Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7609215 | 0.76 | PPARA (0.45) | — | |
| SCHEMBL6966288 | 0.69 | HSD17B10 (0.47) | PTGS1PTGS2 | |
| SCHEMBL6958646 | 0.68 | PPARG (0.42) | PTGS1 | |
| SCHEMBL6964821 | 0.68 | PPARA (0.52) | — | |
| SCHEMBL7584952 | 0.67 | PTGS1 (0.33) | PTGS1PTGS2 | |
| SCHEMBL6966942 | 0.67 | PPARG (0.38) | PTGS1PTGS2 | |
| SCHEMBL9179424 | 0.67 | CA1 (0.53) | PTGS1PTGS2 | |
| SCHEMBL3456562 | 0.66 | ALDH1A3 (0.59) | ALDH1A3 | |
| SCHEMBL9180939 | 0.66 | PTGS1 (0.45) | PTGS1PTGS2 | |
| SCHEMBL6544826 | 0.66 | MEN1 (0.34) | ALDH1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020065274-A1 | METHODS OF USING NOVEL COMPOUNDS AS NEURO-PROTECTIVE AGENTS | PANETTA JILL ANN (US) | 2002-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065274-A1 | METHODS OF USING NOVEL COMPOUNDS AS NEURO-PROTECTIVE AGENTS | NLN, GAP43, TXN2 | ALDH1A3 465/4885PTGS1 453/4885PTGS2 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.